ETF Components for LGHT - Langar Global HealthTech ETF


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
ISRG A 1.35 15.39
GEHC D -0.24 8.56
RMD C -0.54 6.71
IQV F 0.15 6.34
DXCM C -1.82 5.51
PODD B 0.50 5.26
VEEV C -1.77 5.15
PHG F 0.08 4.87
ZBH C -1.83 3.57
BNTX C 4.45 3.53
ALGN D -3.18 2.85
MASI B 1.66 2.46
DOCS C -1.30 2.06
MRNA F -5.62 1.72
PRCT B 2.85 1.27
ALKS C -0.25 0.66
TNDM F -3.09 0.54
IRTC C -1.81 0.44
PRVA C 0.76 0.44
OMCL C -7.90 0.42
LFST C 3.28 0.31
TDOC D -1.33 0.28
PGNY F -1.65 0.25
EVH F -3.24 0.22
SDGR C 3.84 0.21
GDRX F -0.70 0.20
ALHC C -0.67 0.20
PHR F -1.38 0.17
ACCD F 3.25 0.07
MODV D 0.19 0.03
TBRG A 1.87 0.03

Recent News for Langar Global HealthTech ETF & its Holdings

Date Stock Title
Nov 19 BNTX Is BioNTech SE (BNTX) the Best German Stock to Buy Now?
Nov 19 DXCM DexCom Pairs Its Glucose Monitor With ŌURA’s Smart Ring
Nov 19 ISRG 5 Non-Tech Nasdaq Composite High Flyers to Buy for More Gains Ahead
Nov 19 ISRG Intuitive Surgical Is Breaking Ground
Nov 19 MRNA BioNTech started at buy, Moderna at hold by Berenberg
Nov 19 BNTX BioNTech started at buy, Moderna at hold by Berenberg
Nov 19 BNTX BioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It.
Nov 19 DXCM Dexcom invests $75m in ŌURA to forge partnership
Nov 19 EVH Evolent Health, Inc. (EVH): This Small-Cap Stock Is Ready To Explode
Nov 19 DOCS 3 Momentum Anomaly Stocks to Buy as Election Rally Fizzles
Nov 19 RMD BSX Stock Gains From Positive OPTION Trial Data for WATCHMAN FLX
Nov 19 DOCS Looking for Earnings Beat? Buy These 4 Top-Ranked Stocks
Nov 19 VEEV Veeva Announces New Digital Hazard Analysis and Critical Control Point (HACCP) Solution
Nov 19 MRNA HSBC upgrades Moderna to Buy on pipeline potential
Nov 19 DXCM DexCom to invest $75M in smart ring firm ŌURA
Nov 19 DXCM Dexcom and ŌURA Announce Strategic Partnership
Nov 18 VEEV Veeva Systems (VEEV) Rises But Trails Market: What Investors Should Know
Nov 18 OMCL Omnicell announces proposed private placement of $150M of convertible senior notes
Nov 18 OMCL Omnicell Announces Proposed Private Placement of $150 Million of Convertible Senior Notes
Nov 18 MRNA Moderna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS Nomination
LGHT targets the global healthcare technology industry. The fund actively invests in HealthTech companies, which the adviser defines as firms that develop technology designed to create healthcare efficiency by addressing key pain points for patients, providers, payors, and hospitals, including those companies that derive a majority of their revenue from HealthTech products and services. The portfolio construction starts by identifying companies that fit into the advisers HealthTech definition. The remaining companies are screened using a proprietary metric that assesses each firms financial health, involvement in relevant controversies, as well as the strength of its team and culture. Each company is then assigned an industry risk score through an algorithm that defines quantitative and qualitative risk categories and weights them accordingly. Finally, each company is reviewed by an investment committee. However, the portfolio manager still has full discretion over the final selection.
Back to the Main LGHT Page...